Argenx
ARGX
#627
Rank
S$42.29 B
Marketcap
$697.73
Share price
1.25%
Change (1 day)
-2.28%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - P/B ratio

P/B ratio as of September 2024 : 7.52

According to Argenx 's latest financial reports the company has a price-to-book ratio of 7.52.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Argenx - P/B ratio (from 2021 to 2020)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-315.51-26.06%
2022-12-317.452.64%
2021-12-317.265.91%
2020-12-316.8532.03%
2019-12-315.194.43%
2018-12-314.9723.07%
2017-12-314.04
2016-12-31N/A
2015-12-31N/A-100%
2014-12-311.96
2013-12-31N/A